Position in LIVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,085,914
+$4,251,996 QoQ
Shares Held
195,621
+5.1% QoQ
Ownership
0.355%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#50
of 303 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LIVN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Bellevue Group AG holds $553,598,980 across 19 Medical Devices names. LIVN ranks #11 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
947,115 | $85,941,215 | |
| 2 | SYK |
Stryker Corp
|
268,461 | $84,522,261 | |
| 3 | MDT |
Medtronic plc
|
994,233 | $77,778,847 | |
| 4 | EW |
Edwards Lifesciences Corp
|
739,234 | $66,871,107 | |
| 5 | DXCM |
Dexcom Inc
|
822,489 | $55,394,634 | |
| 6 | BSX |
Boston Scientific Corp
|
887,650 | $37,884,902 | |
| 7 | STE |
STERIS plc
|
99,877 | $21,031,099 | |
| 8 | PODD |
Insulet Corp
|
127,498 | $19,411,570 |
All Filings in LIVN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,085,914 | 195,621 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $11,833,918 | 186,185 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||